Anil P. Ranganath - 05 Jun 2024 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
05 Jun 2024
Net transactions value
-$345,187
Form type
4
Filing time
09 Aug 2024, 16:30:19 UTC
Previous filing
04 Aug 2023
Next filing
26 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Sale $95,053 -703 -7.4% $135.21 8,809 05 Jun 2024 Direct F1
transaction TMDX Common Stock Options Exercise $402,651 +4,289 +48% $93.88 13,182 07 Aug 2024 Direct F2
transaction TMDX Common Stock Sale $652,786 -4,289 -33% $152.20 8,893 07 Aug 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -4,289 -29% $0.000000 10,420 07 Aug 2024 Common Stock 4,289 $93.88 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award.
F2 Includes 84 shares of Issuer's Common Stock acquired on June 28, 2024, pursuant to the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan ("ESPP"), for the option period of January 2, 2024 to June 28, 2024. This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on January 2, 2024.
F3 The option vested as to 25% on June 5, 2024 and will vest as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service.

Remarks:

Senior Vice President, General Counsel and Secretary